Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues.
Eos inophilic gastroenteritis should be considered in the differential diagnosis of unexplained gastrointestinal symptoms even in the absence of peripheral eosinophilia, according to the clinicopathological spectrum.
Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota.
PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis
Colorectal neoplasia develops in a substantial fraction and overall survival is worse and PSC-IBD may represent a distinct IBD phenotype.
Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000
The incidence rates of CD and UC increased after 1940, they have remained stable over the past 30 years, and there were 1.1 million people with inflammatory bowel disease in the US in 2000.
The Epidemiology of Community-Acquired Clostridium difficile Infection: A Population-Based Study
- S. Khanna, D. Pardi, A. Zinsmeister
- Medicine, BiologyAmerican Journal of Gastroenterology
- 1 January 2012
In this population-based cohort, a significant proportion of cases of CDI occurred in the community, and patients were younger and had less severe infection than those with hospital-acquired infection.
Correlation of C‐Reactive Protein With Clinical, Endoscopic, Histologic, and Radiographic Activity in Inflammatory Bowel Disease
- C. Solem, E. Loftus, W. Tremaine, W. Harmsen, A. Zinsmeister, W. Sandborn
- MedicineInflammatory Bowel Diseases
- 1 August 2005
CRP elevation in IBD patients is associated with clinical disease activity, endoscopic inflammation, severely active histologic inflammation (in CD patients), and several other biomarkers of inflammation, but not with radiographic activity.
Risk factors for opportunistic infections in patients with inflammatory bowel disease.
Immunosuppressive medications, especially when used in combination, and older age are associated with increased risk of opportunistic infections in inflammatory bowel disease patients.
The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients.
Short- and long-term infliximab therapy is generally well tolerated, however, clinicians must be vigilant for the occurrence of infrequent but serious events, including serum sickness-like reaction, opportunistic infection and sepsis, and autoimmune disorders.
Simplified assessment of segmental colonic transit.
The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study.
At 1 year, 32% of patients with Crohn's disease and 48% with ulcerative colitis are corticosteroid free without operation.